Nothing the critics can say will change the outcome of P trial and partnership negotiations. As we've seen so many times over the years, the market will react to the news.
Excellent track record. The desperation is looking pretty clear to get this as cheap as they can before the market realizes what they're missing out on. A major gap up on partnership news would do it. Good to great prurisol news may do it as well. At that moment, charts are meaningless.